Indispensible in many medical specialties – the seca mBCA

Until now doctors had to use complex methods to get an accurate picture of a patient's body composition. The seca mBCA simplifies that complicated technology and after less than 20 seconds, it delivers all medically relevant data.

Photo: Indispensible in many medical specialties – the seca mBCA

The seca mBCA is the first body composition analysis device in the world that has been validated against the scientific gold standard in four international studies. By using bioelectrical impedance analysis, the seca mBCA ascertains the body's fat and muscle mass and water. Six analytical modules present the measurements in a user-friendly format and offer a precise analysis of body composition that is indispensible in many medical specialties. Alarming developments can be recognized early.

Diabetology
In the treatment of diabetes mellitus Type II, which frequently involves obesity, the doctor can use fat mass as measured by the seca mBCA to calculate energy stores and the patient's total energy expenditure per day. These values are the foundation for a dietary plan to lose weight. The seca mBCA can also determine the success of treatment designed to reduce fat mass and simultaneously increase muscle mass.
The analysis of fat-free mass can assist the doctor with early detection of ischemic edema caused by circulatory disorders.

Nephrology
The seca mBCA provides not only the fast, medically relevant measurement of total body water but also the breakdown into extracellular and intracellular water. The doctor can also keep an eye on the patient's fluid level, fat mass, fat-free mass, skeletal muscle mass and lean body mass. Malnutrition is a significant factor for high mortality risk in cases of kidney insufficiency. "The right fat and muscle mass ratios are vitally important for our dialysis patients," said Dr. Hans-H. Neumayer, Director of the Clinical Center for Nephrology, Charité Universitätsmedizin Berlin.

Nutritional medicine
Both obesity and malnutrition are accompanied by a change in body composition that the treating physician can detect in early stages with the help of the seca mBCA. As the seca mBCA distinguishes, for example, between excess fluid, cachexia and a lean constitution, malnutrition can be reliably diagnosed early. In obesity therapy the seca mBCA closely monitors the success of treatment. At a glance medical personnel can see whether the therapy goal – fat reduction and muscle increase - has been achieved. The information also motivates the patient because he can see that his body composition is changing for the better even when his weight hits a plateau.
 

14.11.2012

Read all latest stories

Related articles

Photo

Article •

EKF Diagnostics launches a new low cost POC HbA1c analyser

EKF Diagnostics, a worldwide manufacturer of point-of-care (POC) in-vitro diagnostic devices, has announced the European launch of its Quo-Lab POC HbA1c analyser.

Photo

News • Pathogen Analyzer

Researchers develop cost-effective PCR test alternative

Speed or accuracy? As far as Covid-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.

Photo

News • Improved disease management

Type 1 diabetes: researchers explore benefits of 'bionic pancreas'

A device using next-gen technology to automatically deliver insulin was found to be more effective at maintaining blood glucose levels than standard-of-care management for type 1 diabetes.

Related products

Nova Biomedical – StatStrip Glucose/Ketone*

Blood Glucose

Nova Biomedical – StatStrip Glucose/Ketone*

Nova Biomedical Corporation
Beckman Coulter – Access 2 Immunoassay System

Immunoassays

Beckman Coulter – Access 2 Immunoassay System

Beckman Coulter Diagnostics
Beckman Coulter – DxA 5000

Automation

Beckman Coulter – DxA 5000

Beckman Coulter Diagnostics
Beckman Coulter – DxM 1096 MicroScan WalkAway system

Automation

Beckman Coulter – DxM 1096 MicroScan WalkAway system

Beckman Coulter Diagnostics
CliniSys – Anatomical Pathology Laboratory

Information Technology

CliniSys – Anatomical Pathology Laboratory

CliniSys Deutschland GmbH
Subscribe to Newsletter